1. Are adjuvant therapies beyond all doubt?

   • Wolfgang Hilbe
   • Eberhard Gunsilius

   Editorial Pages: 53 - 53

2. CECOG News

   • Christoph C. Zielinski

   CECOG News Pages: 54 - 56

3. Adjuvant therapy in non-small cell lung cancer: Current status and future perspectives

   • M. Filipits
   • R. Pirker

   Short review Pages: 57 - 60

4. Adjuvant chemotherapy in stage IB non-small cell lung cancer: if, when, how?

   • M. Dediu

   Short review Pages: 61 - 65

5. (Neo-)Adjuvant treatment of malignant thymoma

   • G. Pall

   Short review Pages: 67 - 69

6. Perioperative therapy in gastric cancer

   • E. Wöll

   Short review Pages: 71 - 73

7. Adjuvant therapy of stage II colorectal cancer – who will benefit from treatment?

   • H. Zwierzina

   Short review Pages: 75 - 77

8. Consensus on the medical treatment of colon cancer

   • G. Kornek
   • W. Scheithauer
   • C. Zielinski

   Consensus report Pages: 79 - 90

9. Adjuvant chemotherapy in breast cancer

   • R. Bartsch
   • G. G. Steger

   Review article Pages: 91 - 98

10. Primary chemotherapy and maintenance therapy in epithelial ovarian cancer

    • A. G. Zeimet
    • D. Reimer
    • C. Marth

    Short review Pages: 99 - 102

11. Congress report: 49th Annual Meeting of the American Society of Haematology, Georgia World Congress Center, December 8–11 2007, Atlanta, Georgia

    • S. Schmidt
    • M. Steurer

    Congress report Pages: 103 - 109

12. Update on the treatment of hepatocellular carcinoma

    • M. Peck-Radosavljevic

    Special article Pages: 111 - 115

13. Announcement

    Announcement Pages: 117 - 118